NicErase-SL: Began Phase II trial.

DynaGen Inc. (DYGN), Cambridge, Mass. Product: NicErase-SL sublingual tablet containing L-lobeline sulfate, a nicotine mimic Indication: Smoking cessation Status: Began Phase II trial in 20 patients ...